跳至主要内容
临床试验/NL-OMON48693
NL-OMON48693尚未招募2 期

The effect of intravenous L-carnitine supplementation during oxaliplatin based chemotherapy on blood- and urinary levels of carnitine - Pilot carnitine supplementation during oxaliplatin infusion

Maxima Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Written informed consent
  • 2. Age >18 years
  • 3. Start treatment with oxaliplatin-based chemotherapy
  • 4. Understanding the Dutch language

排除标准

  • 1. No written informed consent
  • 2. Patients with known primary carnitine deficiency (congenital)
  • 3. Patients on haemodialysis or peritoneal dialysis
  • 4. Patients with epilepsy
  • 5. Current treatment with valproic acid or zidovudine
  • 6. Current use of carnitine supplements or use of carnitine supplements
  • in the past 3 months
  • 7. Pre-existent neuropathy or comorbid disorder causing neuropathy
  • 8. Previous treatment with neurotoxic chemotherapy
  • 9. Participation in an intervention study on CIPN (e.g. Frozen Gloves)
  • 6. Current use of carnitine supplements or use of carnitine supplements in the
  • past 3 months, 7. Pre-existent neuropathy or comorbid disorder causing
  • neuropathy, 8. Previous treatment with neurotoxic chemotherapy, 9.
  • Participation in an intervention study on CIPN (e.g. Frozen Gloves)

研究者

发起方
Maxima Medisch Centrum

相似试验